loadpatents
name:-0.033015966415405
name:-0.025052070617676
name:-0.0039129257202148
PROCOPIOU; Panayiotis Alexandrou Patent Filings

PROCOPIOU; Panayiotis Alexandrou

Patent Applications and Registrations

Patent applications and USPTO patent grants for PROCOPIOU; Panayiotis Alexandrou.The latest application filed is for "naphthyridines as integrin antagonists".

Company Profile
3.26.29
  • PROCOPIOU; Panayiotis Alexandrou - Stevenage GB
  • Procopiou; Panayiotis Alexandrou - Hertfordshire GB
  • Procopiou; Panayiotis Alexandrou - Stevenage Hertfordshire GB
  • Procopiou, Panayiotis Alexandrou - Waterford GB
  • PROCOPIOU, PANAYIOTIS ALEXANDROU - WATFORD GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Naphthyridines As Integrin Antagonists
App 20210206758 - ANDERSON; Niall Andrew ;   et al.
2021-07-08
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
Grant 10,513,517 - Anderson , et al. Dec
2019-12-24
Naphthyridines as integrin antagonists
Grant 10,487,080 - Anderson , et al. Nov
2019-11-26
Naphthyridines As Integrin Antagonists
App 20190112306 - ANDERSON; Niall Andrew ;   et al.
2019-04-18
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases
App 20190048005 - ANDERSON; Niall Andrew ;   et al.
2019-02-14
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
Grant 10,144,733 - Anderson , et al. De
2018-12-04
Compounds alpha v beta 6 integrin antagonists
Grant 10,004,724 - Anderson , et al. June 26, 2
2018-06-26
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
App 20170290818 - ANDERSON; Niall Andrew ;   et al.
2017-10-12
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases
App 20170291899 - ANDERSON; Niall Andrew ;   et al.
2017-10-12
Phenethanolamine derivatives for treatment of respiratory diseases
Grant RE44,874 - Box , et al. April 29, 2
2014-04-29
Compounds
Grant 8,507,543 - Hodgson , et al. August 13, 2
2013-08-13
Novel Compounds
App 20130030031 - HODGSON; Simon Teanby ;   et al.
2013-01-31
Pyrazole derivatives used as CCR4 receptor antagonists
Grant 8,357,716 - Hobbs , et al. January 22, 2
2013-01-22
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 8,198,483 - Box , et al. June 12, 2
2012-06-12
Pyrazole Derivatives Used as CCR4 Receptor Antagonists
App 20120015932 - Hobbs; Heather ;   et al.
2012-01-19
Substituted Quinoline Derivatives As H1 Receptor Antagonists
App 20110281909 - Gore; Paul Martin ;   et al.
2011-11-17
3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
Grant 7,989,629 - Hodgson , et al. August 2, 2
2011-08-02
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,982,067 - Box , et al. July 19, 2
2011-07-19
Compounds
Grant 7,884,114 - Gore , et al. February 8, 2
2011-02-08
Phenethanolamine Derivatives for Treatment of Respiratory Diseases
App 20110009631 - Box; Philip Charles ;   et al.
2011-01-13
Quinoline Derivatives Used To Treat Inflammatory And Allergic Diseases
App 20100222349 - Gore; Paul Martin ;   et al.
2010-09-02
Phthalazine And Pyrido[3,4-d]pyridazine Compounds As H1 Receptor Antagonists
App 20100216799 - Gore; Paul Martin ;   et al.
2010-08-26
Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
Grant 7,776,895 - Box , et al. August 17, 2
2010-08-17
Compounds
App 20090270355 - Gore; Paul Martin ;   et al.
2009-10-29
Medicinal compounds
Grant 7,538,127 - Biggadike , et al. May 26, 2
2009-05-26
2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
App 20090105225 - Gore; Paul Martin ;   et al.
2009-04-23
Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
App 20090068273 - BOX; Philip Charles ;   et al.
2009-03-12
3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders
App 20080312280 - Hodgson; Simon Teanby ;   et al.
2008-12-18
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,442,836 - Biggadike , et al. October 28, 2
2008-10-28
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,442,837 - Biggadike , et al. October 28, 2
2008-10-28
Phenethanolamine derivative for the treatment of respiratory diseases
Grant 7,442,839 - Chapman , et al. October 28, 2
2008-10-28
Methods using phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,442,719 - Biggadike , et al. October 28, 2
2008-10-28
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,439,393 - Box , et al. October 21, 2
2008-10-21
Compounds
App 20080207638 - Ancliff; Rachael Ann ;   et al.
2008-08-28
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,361,787 - Box , et al. April 22, 2
2008-04-22
Phenethanolamine Derivatives for Treatment of Respiratory Diseases
App 20080003290 - Box; Philip Charles ;   et al.
2008-01-03
Process for preparing salmeterol
Grant 7,294,725 - Procopiou November 13, 2
2007-11-13
Phenethanolamine derivatives for treatment of respiratory diseases
App 20070249630 - BLAKE; Keith ;   et al.
2007-10-25
Phenethanolamine derivatives
Grant 7,271,197 - Box , et al. September 18, 2
2007-09-18
Methods using phenethanolamine derivatives for treatment of respiratory diseases
App 20070004807 - Biggadike; Keith ;   et al.
2007-01-04
Phenethanolamine Derivatives For Treatment Of Respiratory Diseases
App 20060287389 - BIGGADIKE; Keith ;   et al.
2006-12-21
Phenethanolamine Derivatives For Treatment Of Respiratory Diseases
App 20060287286 - BIGGADIKE; Keith ;   et al.
2006-12-21
Agonists of beta-adrenoceptors
Grant 7,144,908 - Coe , et al. December 5, 2
2006-12-05
Phenethanolamine derivatives for treatment of respiratory diseases
Grant 7,135,600 - Biggadike , et al. November 14, 2
2006-11-14
Phenethanolamine derivative for the treatment of respiratory diseases
App 20060205794 - Chapman; Alan Michael ;   et al.
2006-09-14
Medicinal compounds
App 20060148771 - Biggadike; Keith ;   et al.
2006-07-06
Phenethanolamine derivatives
App 20050256201 - Box, Philip Charles ;   et al.
2005-11-17
Process for preparing salmeterol
Grant 6,911,560 - Procopiou June 28, 2
2005-06-28
Compounds
App 20050070515 - Angell, Richard Martyn ;   et al.
2005-03-31
Agonists of beta-adrenoceptors
App 20040242890 - Coe, Diane Mary ;   et al.
2004-12-02
Novel process for preparing salmeterol
App 20030162840 - Procopiou, Panayiotis Alexandrou
2003-08-28
Compounds
App 20020019378 - ANGELL, RICHARD MARTYN ;   et al.
2002-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed